Concepedia

Publication | Closed Access

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

DOI

120

Citations

37

References

2010

Year

Scott Ackler, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Stephen K. Tahir, Xiao Yu, Christin Tse, David J. Frost, Stephen W. Fesik,
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1